Physician profile
Richard A Wolf
NPI 1962440552
$1,549.00
in general payments reported to CMS, 2019-2025
19 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,142 · 2020: $148 · 2021: $19.12 · 2022: $27.49 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $213.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $827.03 | 2019-2025 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $149.40 | 2019-2020 | |
| Abiomed | $108.03 | 2019 | |
| Pfizer INC. | $65.12 | 2019-2020 | |
| Itamar Medical INC | $58.66 | 2025 | Watchpatone |
| Livanova USA, INC. | $44.01 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $42.41 | 2019 | |
| Janssen Pharmaceuticals, INC | $32.89 | 2020 | |
| Amgen INC. | $29.23 | 2019 | |
| Bardy Diagnostics, INC. | $27.49 | 2022 | |
| Novo Nordisk INC | $27.40 | 2019 | |
| Novartis Pharmaceuticals Corporation | $22.32 | 2019 | |
| United Therapeutics Corporation | $21.01 | 2019 | |
| Siemens Medical Solutions USA, INC. | $19.12 | 2021 | |
| Amarin Pharma, INC. | $18.01 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $16.92 | 2019 | |
| Janssen Scientific Affairs, LLC | $15.44 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.48 | 2025 | Lifevest |
| Kowa Pharmaceuticals America, INC. | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.